InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.495 0.015 (2.94%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$171 ARX First Clinical Evidence from MASTRR Study Published 23 Dec 2024 8:53AM $0.680 $0.495 fallen by 27.21%
$171 Aroa Half Year Results Presentation 26 Nov 2024 8:45AM $0.650 $0.495 fallen by 23.85%
$171 Aroa Biosurgery Half Yearly Results H1 FY25 26 Nov 2024 8:39AM $0.650 $0.495 fallen by 23.85%
$171 Appendix 4D and Half Year Report 26 Nov 2024 8:38AM $0.650 $0.495 fallen by 23.85%
$171 Notification of Half Year Results Webinar 19 Nov 2024 11:46AM $0.630 $0.495 fallen by 21.43%
$171 Investor Presentation 22 Oct 2024 8:45AM $0.520 $0.495 fallen by 4.81%
$171 September 2024 Quarterly Report and Appendix 4C 22 Oct 2024 8:43AM $0.520 $0.495 fallen by 4.81%
$171 Notification of Quarterly Results Webinar 15 Oct 2024 8:56AM $0.525 $0.495 fallen by 5.71%
$171 Notification of cessation of securities - ARX 11 Oct 2024 10:36AM $0.545 $0.495 fallen by 9.17%
$171 Change of Director's Interest Notice - CM 4 Oct 2024 4:06PM $0.530 $0.495 fallen by 6.60%
$171 Change in substantial holding 27 Aug 2024 4:26PM $0.470 $0.495 risen by 5.32%
$171 Change in substantial holding 26 Aug 2024 3:07PM $0.485 $0.495 risen by 2.06%
$171 Change of Director's Interest Notice - DH 23 Aug 2024 4:01PM $0.453 $0.495 risen by 9.39%
$171 Change of Director's Interest Notice - BW 23 Aug 2024 4:01PM $0.453 $0.495 risen by 9.39%
$171 Notification of cessation of securities - ARX 23 Aug 2024 3:53PM $0.450 $0.495 risen by 10%
$171 Section 708A Notice 23 Aug 2024 3:51PM $0.450 $0.495 risen by 10%
$171 Application for quotation of securities - ARX 23 Aug 2024 3:45PM $0.450 $0.495 risen by 10%
$171 Application for quotation of securities - ARX 23 Aug 2024 3:39PM $0.453 $0.495 risen by 9.39%
$171 Notification regarding unquoted securities - ARX 23 Aug 2024 3:36PM $0.453 $0.495 risen by 9.39%
$171 Investor Presentation 24 Jul 2024 8:54AM $0.620 $0.495 fallen by 20.16%
$171 June 2024 Quarterly Report and Appendix 4C 24 Jul 2024 8:47AM $0.620 $0.495 fallen by 20.16%
$171 Results of Annual General Meeting 23 Jul 2024 1:08PM $0.615 $0.495 fallen by 19.51%
$171 CEO Presentation - AGM 23 Jul 2024 8:39AM $0.610 $0.495 fallen by 18.85%
$171 Chairman's Address - AGM 23 Jul 2024 8:35AM $0.610 $0.495 fallen by 18.85%
$171 Notification of Quarterly Results Webinar 17 Jul 2024 1:41PM $0.620 $0.495 fallen by 20.16%

101 - 125 of 777 results

Page 5 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.